Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer (MASTEC)

NCT07514325 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT07514325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07514325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer (MASTEC)
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
March 1, 2033
Enrollment
61 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, radiotherapy, adjuvant